NDC product
Gralise Starter Pack
NDC 13913-006 · Assertio Therapeutics, Inc.
Key facts
| Product NDC | 13913-006 |
|---|---|
| Proprietary name | Gralise |
| Labeler | Assertio Therapeutics, Inc. |
| Marketing category | NDA |
| Application number | NDA022544 |
| Marketing start | Jan 28, 2011 |
| Marketing end | Dec 31, 2020 |
| Listing certified through | Dec 31, 2020 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: